Androgenetic alopecia (AGA) is a common hair loss disorder caused by genetic and hormonal factors that are characterized by androgen-related progressive thinning of scalp hair in a defined pattern. By the age of 60 years, 45% of men and 35% of women develop AGA. Currently, U.S. Food and Drug Administration-approved treatments for AGA include oral finasteride and topical minoxidil. Due to the limited number of effective therapies for AGA, platelet-rich plasma (PRP) has become an effective alternative treatment. PRP is an autologous concentration of platelets in plasma with numerous growth factors that contribute to hair regeneration. The growth factors contained within the alpha granules of platelets act on stem cells in the bulge area of the hair follicles and stimulate the development of new follicles along with neovascularization. PRP has become a promising treatment modality for AGA. Although there have been several studies
Hair loss can cause considerable psychological and emotional distress and decreased quality of life. Therefore, developing a safe and effective treatment modality can greatly benefit patients in a dermatology practice setting. Current treatment options include minoxidil, finasteride, spironolactone, nutritional supplementation, low-level light therapy, and hair transplantation surgery. Although topical minoxidil and oral finasteride are approved by the U.S. Food and Drug Administration, they have drawbacks including limited degree of clinical improvement in some patients. The efficacy of new hair growth with current U.S. Food and Drug Administration-approved therapies can be unsatisfactory and significant improvement is not always observed.
Platelet-rich plasma (PRP) is a treatment modality that has gained popularity for AGA due to its autologous nature, minimal invasiveness, absence of major side effects, and more affordable cost compared with hair restoration surgery.
There are various conditions which could lead to hair loss in women. One of the most common causes of hair loss in women is Anaemia. The other conditions are Thyroid abnormalities, PCOD, Telogen effluvium etc.